Recombinant Danio rerio Tetratricopeptide repeat protein 36 (ttc36)

What is Tetratricopeptide repeat protein 36 (ttc36) and what is its significance in zebrafish research?

Tetratricopeptide repeat protein 36 (ttc36) is a protein containing tetratricopeptide repeat domains found in Danio rerio (zebrafish). In zebrafish, it is also known by the gene identifier zgc:103600. TTC36 belongs to a family of proteins characterized by the presence of tetratricopeptide repeat (TPR) motifs, which are structural motifs that mediate protein-protein interactions. The significance of ttc36 in zebrafish research lies primarily in its critical role in cilia formation and motility, making it an important model for studying ciliopathies in vertebrates. Research has demonstrated that ttc36 is one of four novel TTC genes (including ttc4, ttc9c, and ttc39c) that have been identified as essential for proper cilia development and function in zebrafish . The study of ttc36 provides valuable insights into the molecular mechanisms underlying ciliary development, a process that is fundamentally important across vertebrate species including humans.

How is recombinant ttc36 typically produced and what expression systems are most effective?

Recombinant Danio rerio ttc36 can be produced using several expression systems, with the choice depending on research objectives and downstream applications. Commonly used expression systems include E. coli, yeast, baculovirus, and mammalian cell systems . Each system offers distinct advantages and limitations. E. coli systems are typically favored for their simplicity, cost-effectiveness, and high protein yield, though they may lack some post-translational modifications. For functional studies requiring proper protein folding and post-translational modifications, mammalian or baculovirus expression systems are often preferred. The production process generally involves cloning the full-length cDNA of zebrafish ttc36 (accession number NM_001007388) into appropriate expression vectors, followed by transformation or transfection into the host system . Purification typically utilizes affinity chromatography, with final purity levels of recombinant ttc36 commonly reaching greater than or equal to 85% as determined by SDS-PAGE analysis . The choice of expression system should be guided by the specific requirements of the intended experimental applications.

What are the key structural domains of ttc36 and how do they relate to its function?

The primary structural feature of ttc36 is the presence of tetratricopeptide repeat (TPR) domains, which define the TTC protein family. TPR domains consist of degenerate 34-amino acid sequences that form helix-turn-helix arrangements, typically occurring in tandem arrays. These domains create extended scaffolds that mediate specific protein-protein interactions, which are crucial for the assembly of multiprotein complexes. In the context of ttc36 function, these TPR domains appear to facilitate interactions with components of intraflagellar transport (IFT) complexes, specifically elements of IFT-A, IFT-B, or BBSome complexes . These interactions are essential for ttc36's role in cilia formation and motility. The TPR domains likely determine the specificity of these interactions, enabling ttc36 to participate in the precise molecular assembly required for proper ciliary development and function. Understanding the structural characteristics of these domains provides insights into how mutations might disrupt protein function, potentially leading to ciliopathies or other developmental abnormalities in zebrafish and other vertebrates.

What are the recommended protocols for knocking down ttc36 expression in zebrafish embryos?

The most effective approach for knocking down ttc36 expression in zebrafish embryos involves morpholino oligonucleotide (MO) injection. The specific morpholino sequence targeting zebrafish ttc36 is 5'-CTGCTCTGTCGTGTGCTGATGCCAT-3' . For optimal results, morpholinos should be dissolved in nuclease-free water and injected into the yolk of one-cell-stage zebrafish embryos using a microinjector such as the Narishige IM300. Based on established protocols, a dosage of 8 ng per embryo is typically used for initial screening . The efficacy of morpholino knockdown should be verified using a GFP reporter system, where an approximately 200-bp fragment of zebrafish ttc36 cDNA containing the MO targeting sequence is cloned upstream of and in frame with EGFP coding sequence. The mRNA for this reporter construct should be co-injected with either the ttc36-targeting MO or a control MO, with GFP expression monitored at approximately 12 hours post-fertilization (hpf). Reduction in GFP signal confirms successful knockdown. For phenotypic analysis, embryos should be examined at 72 hpf for ciliopathy-related features including curved body, abnormal otoliths, hydrocephalus, and left-right patterning defects .

How can researchers effectively validate the specificity of ttc36 knockdown and rule out off-target effects?

Validating the specificity of ttc36 knockdown and ruling out off-target effects requires a multi-faceted approach. The primary validation method involves rescue experiments using ttc36 mRNA that has been rendered morpholino-resistant. This can be achieved by introducing five mismatched synonym nucleotides in the MO-targeting sequence without altering the amino acid sequence . The modified cDNA should be subcloned into an expression vector such as pCS2+ for synthesis of capped mRNAs. For rescue experiments, 400 pg of in-vitro transcribed mRNA per embryo should be co-injected with the ttc36 morpholino . Successful rescue, indicated by reduction in the percentage of embryos displaying ciliopathy-related phenotypes, confirms that the observed phenotypes are specifically due to ttc36 knockdown rather than off-target effects. Additionally, researchers should employ a GFP reporter system to directly visualize morpholino efficiency, using a construct containing the MO target sequence fused to GFP. Finally, phenotypic comparison with other known methods of disrupting the same pathway (e.g., CRISPR/Cas9 targeting of ttc36 or disruption of interacting partners) can provide further confirmation of specificity. Quantitative RT-PCR can also be used to verify reduction of ttc36 transcript levels following morpholino injection.

What methods are most effective for detecting protein-protein interactions involving ttc36 in zebrafish?

For investigating protein-protein interactions involving ttc36 in zebrafish, several complementary approaches yield the most comprehensive and reliable results. Immunoprecipitation (IP) represents a primary method, allowing researchers to identify proteins that physically associate with ttc36 . For this technique, antibodies specific to ttc36 or to an epitope tag on recombinant ttc36 are used to pull down the protein complex from zebrafish tissue lysates, followed by mass spectrometry or western blot analysis to identify interacting partners. To examine interactions in a cellular context, proximity ligation assays (PLA) can visualize protein-protein interactions in situ with high sensitivity and specificity. For screening potential interactions, yeast two-hybrid (Y2H) systems can be employed, where ttc36 is used as bait to identify interacting partners from a zebrafish cDNA library. For confirmation of direct interactions, in vitro techniques such as GST pull-down assays using recombinant ttc36 can be utilized. Additionally, bimolecular fluorescence complementation (BiFC) allows visualization of interactions in living cells by fusing potential interacting partners to complementary fragments of a fluorescent protein. Studies have shown that ttc36 associates with components of intraflagellar transport complexes including IFT-A, IFT-B, or BBSome , making these methods particularly valuable for investigating the molecular mechanisms underlying ttc36's role in ciliary formation and function.

How does ttc36 contribute to cilia formation and motility in zebrafish?

Ttc36 plays a critical role in cilia formation and motility in zebrafish through its interactions with key components of the ciliary transport machinery. Research has demonstrated that ttc36 is among four novel TTC genes (ttc4, -9c, -36, and -39c) that are essential for proper ciliogenesis . At the molecular level, ttc36 appears to function through association with components of intraflagellar transport (IFT) complexes, specifically elements of IFT-A, IFT-B, or BBSome complexes as demonstrated by immunoprecipitation studies . These interactions suggest that ttc36 participates in IFT or IFT-related activities, which are fundamental processes required for the assembly and maintenance of cilia. The tetratricopeptide repeat domains in ttc36 likely facilitate these protein-protein interactions, serving as scaffolds for the assembly of multiprotein complexes essential for ciliary transport. The functional significance of ttc36 in ciliogenesis is evidenced by the phenotypes observed in ttc36 morphants, which display classic ciliopathy-related features including curved body, abnormal otolith formation, hydrocephalus, and defective left-right patterning . These phenotypes closely resemble those seen in other zebrafish models of ciliary dysfunction, reinforcing ttc36's critical contribution to cilia formation and function.

What is the relationship between ttc36 and human ciliopathies, and how can zebrafish models inform human disease research?

The relationship between ttc36 and human ciliopathies is an emerging area of research with significant implications for understanding disease mechanisms. Although direct human orthologs and their specific roles in human disease have not been fully characterized in the provided research, the zebrafish ttc36 model offers valuable insights into potential disease mechanisms. Zebrafish ttc36 morphants display phenotypes that closely mirror human ciliopathies, including curved body axis (analogous to scoliosis in humans), hydrocephalus, and left-right patterning defects . These phenotypes suggest that ttc36 dysfunction could contribute to human ciliopathies such as primary ciliary dyskinesia, Joubert syndrome, Bardet-Biedl syndrome, or Meckel syndrome. The association of ttc36 with IFT components and BBSome complexes is particularly significant, as mutations in BBSome proteins are known causes of Bardet-Biedl syndrome in humans . Zebrafish models offer several advantages for studying these relationships, including rapid development, optical transparency, and genetic tractability. By examining the molecular mechanisms through which ttc36 influences cilia formation in zebrafish, researchers can identify potential therapeutic targets and pathways relevant to human ciliopathies. Furthermore, the zebrafish model allows for high-throughput screening of compounds that might rescue ciliopathy phenotypes, potentially accelerating drug discovery for these often untreatable human conditions.

How can large-scale peptidomics approaches be applied to study ttc36 and related proteins in zebrafish?

Large-scale peptidomics approaches offer sophisticated tools for studying ttc36 and related proteins in zebrafish, providing insights into protein expression, modification, and interaction networks. Peptidomics, which aims to identify and characterize the endogenously present peptide complement of a defined tissue or organism using liquid chromatography and mass spectrometry , can be particularly valuable in the context of ttc36 research. For studying ttc36, researchers can apply tissue-specific peptidomics to isolate and characterize ttc36 and its interacting partners from relevant zebrafish tissues, such as those rich in ciliated cells. This approach would involve tissue extraction, fractionation, LC-MS/MS analysis, and bioinformatic identification of peptides. The methodology has already been successfully applied to identify over 60 different peptides and various truncated versions in zebrafish brain tissue , demonstrating its feasibility for comprehensive protein characterization. Differential peptidomics can be particularly valuable, allowing researchers to examine changes in ttc36 expression or post-translational modifications in response to genetic manipulations, environmental challenges, or developmental stages . This approach could reveal how ttc36 function is regulated and how it contributes to ciliopathies when dysregulated. By integrating peptidomics data with other -omics approaches (transcriptomics, genomics), researchers can construct comprehensive molecular networks that place ttc36 in its broader functional context within ciliary development and maintenance.

What are the characteristic phenotypes of ttc36 knockdown in zebrafish, and how are they quantified?

Ttc36 knockdown in zebrafish produces a distinct set of ciliopathy-related phenotypes that can be systematically quantified. The most prominent phenotype is a curved body axis, which affects more than 84% of ttc36 morphants by 72 hours post-fertilization (hpf) . This curvature typically manifests as a ventral curvature of the tail and can be quantified by measuring the angle of deviation from a straight line drawn from head to tail. Additional characteristic phenotypes include abnormal otolith formation in the otic vesicle, hydrocephalus (brain ventricle enlargement), and defective left-right patterning of organs such as the heart . Otolith abnormalities can be classified and quantified based on number, size, and position within the otic vesicle. Hydrocephalus can be quantified by measuring ventricle diameter or volume using microscopy and image analysis software. Left-right patterning defects can be assessed by examining heart looping direction and the expression patterns of laterality markers using in situ hybridization. For each phenotype, researchers typically analyze at least 30-50 embryos per experimental group and express results as the percentage of affected embryos. Statistical analysis using chi-square tests for categorical data or t-tests/ANOVA for continuous measurements can determine the significance of differences between morphants and controls. This comprehensive phenotypic analysis provides a quantitative foundation for understanding ttc36 function in ciliary development.

How can rescue experiments be designed to confirm the specificity of ttc36 knockdown phenotypes?

Rescue experiments for confirming the specificity of ttc36 knockdown phenotypes require careful design to ensure interpretable results. The fundamental approach involves co-injecting morpholino-resistant ttc36 mRNA along with the ttc36-targeting morpholino. To create morpholino-resistant mRNA, researchers should introduce five mismatched synonym nucleotides in the morpholino-targeting sequence of the ttc36 cDNA without altering the amino acid sequence . This modified cDNA should be subcloned into an expression vector such as pCS2+ for in vitro synthesis of capped mRNAs using systems like the mMESSAGE mMACHINE SP6 kit . For effective rescue, 400 pg of in vitro transcribed mRNA should be co-injected with the morpholino into one-cell-stage zebrafish embryos . Control groups should include uninjected embryos, embryos injected with control morpholino, embryos injected with ttc36 morpholino alone, and embryos injected with the rescue mRNA alone. Phenotypic rescue should be assessed at 72 hpf by quantifying the percentage of embryos displaying ciliopathy-related phenotypes in each group. A significant reduction in phenotype frequency in the rescued group compared to the morpholino-only group confirms specificity. For more rigorous validation, dose-response experiments using varying amounts of rescue mRNA can establish a relationship between ttc36 expression levels and phenotypic rescue. Additionally, rescue experiments using human orthologs can provide insights into functional conservation across species.

What experimental approaches can determine if ttc36 interacts with intraflagellar transport (IFT) complexes and BBSome components?

Determining interactions between ttc36 and components of intraflagellar transport (IFT) complexes or BBSome requires a multi-faceted experimental approach. Co-immunoprecipitation (Co-IP) represents the primary method, where antibodies against ttc36 or epitope-tagged ttc36 are used to pull down protein complexes from zebrafish embryo lysates, followed by western blotting with antibodies against specific IFT-A, IFT-B, or BBSome components . For comprehensive identification of interacting partners, immunoprecipitated complexes can be analyzed by mass spectrometry. Proximity ligation assays (PLA) offer an in situ approach to visualize interactions within ciliated cells, providing spatial information about where these interactions occur. For direct binding studies, in vitro techniques such as GST pull-down assays using recombinant ttc36, IFT, and BBSome components can determine if interactions are direct or mediated by other proteins. Functional interdependence can be assessed through genetic interaction studies, where subthreshold doses of morpholinos targeting ttc36 and specific IFT/BBSome components are co-injected to look for synergistic effects. Localization studies using immunofluorescence or fluorescently-tagged proteins can determine if ttc36 co-localizes with IFT/BBSome components in cilia. Additionally, ciliary transport assays monitoring the movement of fluorescently-tagged ttc36 in cilia can assess if its trafficking depends on IFT machinery. Research has already established associations between ttc36 and components of IFT-A, IFT-B, or BBSome complexes , providing a foundation for more detailed interaction studies.

How might CRISPR/Cas9 genome editing advance ttc36 research beyond morpholino knockdown approaches?

CRISPR/Cas9 genome editing represents a transformative approach for ttc36 research, offering several significant advantages over morpholino knockdown methodologies. Unlike morpholinos, which provide temporary knockdown with potential off-target effects, CRISPR/Cas9 can generate stable germline mutations in ttc36, creating zebrafish lines with complete gene knockout. This approach enables the study of ttc36 function throughout the entire lifespan, including adult stages that are inaccessible with morpholinos due to their transient nature. CRISPR/Cas9 also allows for precise gene editing, facilitating the introduction of specific mutations that mimic human disease variants, thereby creating more accurate disease models. Additionally, the technology permits the generation of conditional knockouts using inducible or tissue-specific CRISPR systems, enabling temporal and spatial control over ttc36 inactivation. For protein localization and interaction studies, CRISPR/Cas9 can be used to introduce fluorescent tags or epitope tags at the endogenous ttc36 locus, ensuring physiologically relevant expression levels. Furthermore, multiplex CRISPR targeting can facilitate the simultaneous knockout of ttc36 and interacting partners to study genetic interactions and redundancy. Beyond gene knockout, CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) systems offer nuanced approaches to modulate ttc36 expression without altering the genetic sequence. These advanced CRISPR applications would significantly enhance our understanding of ttc36's role in ciliary development and related disorders.

What high-throughput screening approaches could identify small molecules affecting ttc36 function or rescuing ttc36-related phenotypes?

High-throughput screening (HTS) approaches offer powerful strategies for identifying small molecules that modulate ttc36 function or rescue ttc36-related phenotypes in zebrafish. Phenotype-based screens represent an accessible starting point, where zebrafish ttc36 morphants or mutants are exposed to chemical libraries, with compounds that rescue ciliopathy phenotypes (curved body, abnormal otoliths, hydrocephalus) selected for further investigation. Automated imaging platforms coupled with machine learning algorithms can enhance the efficiency and objectivity of phenotypic assessment. For more targeted approaches, cell-based screens using reporter systems that monitor ciliary formation or function in ttc36-deficient cells can identify compounds that restore these processes. Protein-protein interaction screens, such as high-throughput bioluminescence resonance energy transfer (BRET) or split-luciferase assays, can identify molecules that specifically modulate ttc36's interactions with IFT or BBSome components. Additionally, targeted degradation approaches using PROTACs (Proteolysis Targeting Chimeras) could be employed to selectively degrade ttc36 or its interacting partners, providing temporal control over protein function. For identification of potential binding sites, computational approaches such as molecular docking and virtual screening can predict small molecules likely to interact with ttc36. Once promising compounds are identified, structure-activity relationship studies can optimize their properties, followed by detailed mechanistic investigations to determine their precise mode of action. These HTS approaches hold significant potential for developing therapeutic strategies for ciliopathies associated with ttc36 dysfunction.

How can single-cell transcriptomics and proteomics advance our understanding of ttc36 expression patterns and function during zebrafish development?

Single-cell transcriptomics and proteomics offer unprecedented resolution for investigating ttc36 expression patterns and function during zebrafish development. Through single-cell RNA sequencing (scRNA-seq), researchers can generate comprehensive cell type-specific expression maps of ttc36 across developmental stages, revealing precisely which cell populations express ttc36 and how this expression changes temporally. This approach can identify previously unrecognized cell types that express ttc36, potentially revealing novel functions beyond ciliary development. When applied to ttc36 morphants or mutants, scRNA-seq can elucidate cell-specific transcriptional responses to ttc36 deficiency, providing insights into downstream pathways and compensatory mechanisms. Integrating spatial transcriptomics techniques, such as Slide-seq or MERFISH, can preserve spatial information about ttc36 expression within tissues, correlating expression patterns with anatomical features. At the protein level, single-cell proteomics using mass cytometry (CyTOF) or microfluidic approaches can quantify ttc36 protein levels and post-translational modifications across diverse cell populations. These techniques can also analyze co-expression patterns of ttc36 with IFT components and other ciliary proteins at single-cell resolution. Trajectory inference algorithms applied to single-cell data can reconstruct the developmental lineages of ttc36-expressing cells, revealing how ttc36 contributes to cell fate decisions. For functional studies, CRISPR screens combined with single-cell readouts can systematically identify genes that interact with ttc36 in specific cell types. These advanced single-cell approaches promise to transform our understanding of ttc36 biology, revealing cell type-specific functions and regulatory mechanisms that may be obscured in bulk analyses.